| GERN Snapshot | |
|---|---|
| Geron Corporation, an advanced stage clinical biopharmaceutical company, focuses on the development and commercialization of therapies for myeloid hematologic neoplasms. The company is headquartered in Foster City, California. | |
| VALUATION DATA | |
| Market Capitalization | $2,196,500,000 | Price to Sales | 0.00 |
| Earnings per Share | $-0.3200 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $3.7300 |
| 52 Week High | $9031.79 |
| 52 Week Low | $8.64 |
| 50-Day Moving Average | $7998.63 |
| 200-Day Moving Average | $-10.85 |
| All data are from Alpha Vantage as of today. For more infomation on GERN see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search